Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ONCY | BMY | AMGN | GILD | REGN |
| Company | Oncolytics Biotech Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0800 | 77.31 | 253.50 | 64.43 | 685.72 |
| High | 1.1500 | 77.45 | 256.23 | 64.84 | 693.81 |
| Low | 1.0800 | 75.46 | 250.92 | 63.90 | 680.00 |
| Last | 1.1200 | 76.14 | 255.26 | 64.80 | 692.80 |
| Change | +0.0400 | -1.45 | +2.21 | +0.33 | +9.36 |
| % Change | +3.70% | -1.87% | +0.87% | +0.51% | +1.37% |
| Volume | 70,400 | 16,309,400 | 2,678,900 | 6,435,900 | 558,400 |
| 20-Day Average Volume | 85,120 | 15,175,330 | 3,165,495 | 8,223,005 | 648,310 |
| Previous Close | 1.0800 | 77.59 | 253.05 | 64.47 | 683.44 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1832 | 76.46 | 243.32 | 62.61 | 653.91 |
| 20-Day Raw Stochastic | 23.26% | 43.81% | 96.64% | 89.54% | 93.30% |
| 20-Day Relative Strength | 38.68% | 52.42% | 64.52% | 60.48% | 56.79% |
| Weighted Alpha | -64.54 | +22.53 | +13.36 | -4.16 | +31.22 |
| Today's Opinion | 100% Sell | 80% Buy | 88% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 96% Buy | 88% Buy | 24% Sell | 72% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 64% Buy | 56% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.67% since 05/20/22 | -0.07% since 05/20/22 | +3.14% since 05/20/22 | +1.50% since 05/20/22 | +4.79% since 05/20/22 |
| Low | 1.0200 on 05/24/22 | 75.46 on 05/27/22 | 247.88 on 05/23/22 | 63.43 on 05/24/22 | 667.75 on 05/24/22 |
| High | 1.1500 on 05/27/22 | 78.61 on 05/26/22 | 256.23 on 05/27/22 | 65.46 on 05/26/22 | 699.63 on 05/25/22 |
| 1-Month | |||||
| %Chg | -16.42% since 04/27/22 | +0.44% since 04/27/22 | +2.60% since 04/27/22 | +5.21% since 04/27/22 | +2.86% since 04/27/22 |
| Low | 1.0200 on 05/24/22 | 73.35 on 04/29/22 | 227.32 on 05/02/22 | 59.15 on 05/02/22 | 597.76 on 05/09/22 |
| High | 1.4500 on 05/05/22 | 78.61 on 05/26/22 | 256.23 on 05/27/22 | 65.46 on 05/26/22 | 699.63 on 05/25/22 |
| 3-Month | |||||
| %Chg | -33.33% since 02/25/22 | +10.67% since 02/25/22 | +12.43% since 02/25/22 | +6.02% since 02/25/22 | +11.98% since 02/25/22 |
| Low | 1.0200 on 05/24/22 | 67.29 on 02/28/22 | 222.53 on 02/28/22 | 57.19 on 03/16/22 | 597.76 on 05/09/22 |
| High | 1.7600 on 03/01/22 | 78.61 on 05/26/22 | 258.45 on 04/11/22 | 65.46 on 05/26/22 | 747.42 on 04/08/22 |
| 6-Month | |||||
| %Chg | -38.12% since 11/26/21 | +34.69% since 11/26/21 | +26.94% since 11/26/21 | -7.78% since 11/26/21 | +7.69% since 11/26/21 |
| Low | 1.0200 on 05/24/22 | 53.22 on 11/30/21 | 198.64 on 12/01/21 | 57.19 on 03/16/22 | 592.86 on 01/07/22 |
| High | 2.0800 on 02/10/22 | 78.61 on 05/26/22 | 258.45 on 04/11/22 | 74.12 on 12/30/21 | 747.42 on 04/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 62,245 | 165,194,064 | 135,179,312 | 80,865,560 | 74,179,896 |
| Shares Outstanding, K | 57,634 | 2,129,064 | 534,200 | 1,254,313 | 108,539 |
| Annual Sales | 0 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -20,990,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 0 | 11,648,000,000 | 6,238,000,000 | 6,590,000,000 | 2,965,100,000 |
| Last Quarter Net Income | -5,350,000 | 1,278,000,000 | 1,476,000,000 | 19,000,000 | 973,500,000 |
| 60-Month Beta | 2.32 | 0.49 | 0.58 | 0.38 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 05/05/22 | 1.96 on 04/29/22 | 4.25 on 04/27/22 | 2.12 on 04/28/22 | 11.49 on 05/04/22 |
| Latest Earnings Date | 05/05/22 | 04/29/22 | 04/27/22 | 04/28/22 | 05/04/22 |
| Most Recent Dividend | N/A | 0.540 on 03/31/22 | 1.940 on 05/16/22 | 0.730 on 03/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 03/31/22 | 05/16/22 | 06/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.01 | 14.33 | 8.87 | 8.80 |
